Cord Blood

Because cord blood present within a newborn’s umbilical is rich with stem cells, it can be collected and stored for future medical use.

How is Public Cord Blood Banking Funded?

December 28, 2022 By Cade Hildreth, Founder & President Leave a Comment

Currently, it costs a public bank approximately USD $2,000 to collect, test, and process a unit of cord blood for storage. In order to accept donations at no cost, public banks require income to support themselves. This income can come from federal funding, the profit margin of private banking, or from selling donated cord blood units for research. Alternatively, it can come from a combination of the above.

[Read more…]

Therapeutic Solutions International Launches Spin-Off Breathe Biologics Aimed at Curing COPD

November 28, 2022 By Cade Hildreth, Founder & President Leave a Comment

Phase III Clinical Trial Stem Cell Company Aims to Fast Forward Regenerative Solutions to Dreaded Lung Disease

November 9, 2022, ELK CITY, Idaho — Therapeutic Solutions International (TSOI) announced the launching of a spin-off company, Breathe Biologics, Inc., to commercialize technologies in the area of COPD. [Read more…]

Market for cord blood and perinatal tissue in 2022

November 6, 2022 By Cade Hildreth, Founder & President Leave a Comment

Over the past 30 years, cord blood and cord tissue have gained popularity and commercial traction due to the valuable stem cells they contain. According to ClinicalTrials.gov, there are over 1,360 clinical trials evaluating the use of cord blood and tissue-derived cells. These studies typically leverage unmanipulated whole cord blood (total nucleated cells/TNC), mononuclear cells (MNC), or cord blood-derived mesenchymal stem cells (MSCs). [Read more…]

Americord® Releases Exosomes Banking with CryoMaxx™ Processing

October 14, 2022 By Cade Hildreth, Founder & President Leave a Comment

Americord Registry announces the addition of exosome banking to their suite services, becoming the first company in the United States to do so.

NEW YORK, NEW YORK, US, October 11, 2022 – Americord Registry^®, a leader in the cord blood industry, announced the addition of exosome banking to their suite of family-focused services, becoming the first private biobanking company in the United States to do so. Exosomes are tiny, extracellular vesicles that initiate cell-to-cell communication by shuttling cellular components to other cells. Pre-clinical research has shown that exosomes may regulate immune responses, wound healing, and cell growth and development. [Read more…]

Cord Blood Banking in India, a Country That is Home to 1.8 Billion

October 2, 2022 By Cade Hildreth, Founder & President Leave a Comment

ReeLabs is an important cord blood banking brand within India. Cord blood banking in this region is of historic importance, because India has an astounding population of 1.4 billion. Representing 18% of the global population, nearly one-in-five people lives in India, placing it head-to-head with China as the world’s most populous country. India’s population growth is fueled by a birth rate (19 births/1,000 population) that substantially exceeds its death rate (7.3 deaths/1,000 population).

If you’re involved with cord blood banking, then you need to pay attention to this enormous consumer market.

In this interview with Dr. Abhijit Bopardikar, Director of ReeLabs, he explains the rise of cord blood banking within India and discusses the importance of pairing stem cell therapy and research applications with stem cell storage services.